lncR-GAS5 upregulates the splicing factor SRSF10 to impair endothelial autophagy, leading to atherogenesis
Frontiers of Medicine · 2023
DOI: 10.1007/s11684-022-0931-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers of Medicine, 2023. Verfasst von Yuhua Fan und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Medicine Research…. Hauptthemen laut MEDLINE: Atherosclerosis, MicroRNAs, RNA, Long Noncoding. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Abstract (Originalsprache)
Long noncoding RNAs (lncRNAs) play a critical role in the regulation of atherosclerosis. Here, we investigated the role of the lncRNA growth arrest-specific 5 (lncR-GAS5) in atherogenesis. We found that the enforced expression of lncR-GAS5 contributed to the development of atherosclerosis, which presented as increased plaque size and reduced collagen content. Moreover, impaired autophagy was observed, as shown by a decreased LC3II/LC3I protein ratio and an elevated P62 level in lncR-GAS5-overexpressing human aortic endothelial cells. By contrast, lncR-GAS5 knockdown promoted autophagy. Moreover, serine/arginine-rich splicing factor 10 (SRSF10) knockdown increased the LC3II/LC3I ratio and decreased the P62 level, thus enhancing the formation of autophagic vacuoles, autolysosomes, and autophagosomes. Mechanistically, lncR-GAS5 regulated the downstream splicing factor SRSF10 to impair autophagy in the endothelium, which was reversed by the knockdown of SRSF10. Further results revealed that overexpression of the lncR-GAS5-targeted gene miR-193-5p promoted autophagy and autophagic vacuole accumulation by repressing its direct target gene, SRSF10. Notably, miR-193-5p overexpression decreased plaque size and increased collagen content. Altogether, these findings demonstrate that lncR-GAS5 partially contributes to atherogenesis and plaque instability by impairing endothelial autophagy. In conclusion, lncR-GAS5 overexpression arrested endothelial autophagy through the miR-193-5p/SRSF10 signaling pathway. Thus, miR-193-5p/SRSF10 may serve as a novel treatment target for atherosclerosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Medicine Research, Ministry of Education, College of Pharmacy, Harbin Medical Universit…
- Department of Pathology and Pathophysiology, College of Basic Medical Sciences, Harbin Medical University-Daqing, Daqing, 163319, China.
- Center for Drug Research and Development, Guangdong Pharmaceutical University, Guangzhou, 510006, China.
Zitieren
APA
Fan, Y., Zhang, Y., Zhao, H., Liu, W., Xu, W., Jiang, L., Xu, R., Zheng, Y., Tang, X., Li, X., Zhao, L., Liu, X., Hong, Y., Lin, Y., Chen, H., & Zhang, Y. (2023). lncR-GAS5 upregulates the splicing factor SRSF10 to impair endothelial autophagy, leading to atherogenesis. Frontiers of Medicine. https://doi.org/10.1007/s11684-022-0931-4
Vancouver
Fan Y, Zhang Y, Zhao H, Liu W, Xu W, Jiang L, et al. lncR-GAS5 upregulates the splicing factor SRSF10 to impair endothelial autophagy, leading to atherogenesis. Frontiers of Medicine. 2023. doi:10.1007/s11684-022-0931-4
BibTeX
@article{Fan2023,
author = {Fan, Yuhua and Zhang, Yue and Zhao, Hongrui and Liu, Wenfeng and Xu, Wanqing and Jiang, Lintong and Xu, Ranchen and Zheng, Yue and Tang, Xueqing and Li, Xiaohan and Zhao, Limin and Liu, Xin and Hong, Yang and Lin, Yuan and Chen, Hui and Zhang, Yong},
title = {lncR-GAS5 upregulates the splicing factor SRSF10 to impair endothelial autophagy, leading to atherogenesis},
journal = {Frontiers of Medicine},
year = {2023},
doi = {10.1007/s11684-022-0931-4}
}
EUVIMED